'Melting Curve Analysis' Provides New Tool for Assessing Malignant Hyperthermia Risk

A new DNA test may make it much simpler to identify patients at risk of malignant hyperthermia (MH)--a rare but life-threatening complication of exposure to common anesthetics reports the November issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

Read the whole article on Newswise - Scinews

More from Newswise - Scinews